Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Doctor-pharma relationships ‘can’t be trusted’

January 16, 2014 Sales and Marketing BMJ, NHS, doctors, pharma

 A US doctor has warned that patients will lose trust in healthcare professionals if they do not disclose the extent …
News

GSK has Tafinlar ‘breakthrough’

January 15, 2014 Sales and Marketing Cancer, FDA, GSK, NSCLC, Tafinlar

GlaxoSmithKline is on a roll, with its cancer drug Tafinlar given breakthrough therapy designation by the FDA in lung cancer …
News

AZ bullish on its future – but analysts wary

January 15, 2014 Sales and Marketing AstraZeneca, Roche, analysts, jp morgan

AstraZeneca is combating fears over its long-term future by assuring investors that it has the pipeline and the tenacity to …
News

ICON hires Dr Steve Cutler as chief operating officer

January 15, 2014 Manufacturing and Production, Research and Development, Sales and Marketing ICON, cutler

Clinical research organisation ICON has appointed Dr Steve Cutler to the newly created position of chief operating officer (COO).
Appointment

UK cancer figures rise

January 15, 2014 Research and Development, Sales and Marketing Cancer, England, NHS, research uk

More people are being diagnosed with cancer than ever before, according to figures from Cancer Research UK – as an …
News

Bayer and Regeneron to co-develop wet AMD antibody

January 14, 2014 Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD

Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …
News

FDA approves GSK cancer combo

January 14, 2014 Research and Development, Sales and Marketing FDA, GSK, Tafinlar, mekinist

US regulators have shown the green light to a combination of two GlaxoSmithKline skin cancer drugs, Mekinist and Tafinlar, to …
News

Sanofi signs new genetics deal with Isarna

January 14, 2014 Manufacturing and Production, Research and Development, Sales and Marketing DNA, RNA, Sanofi, aso, isarna

Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …
News

Incyte names former Novartis president as its chief executive

January 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Incyte, Novartis, hoppenot

Biopharma firm Incyte has announced that the former president of Novartis Oncology has been named as its president and chief …
Appointment

GSK makes imaging deal

January 14, 2014 Manufacturing and Production, Sales and Marketing 3D, GSK, imaging, npl

GlaxoSmithKline has signed a deal with the National Physical Laboratory (NPL) to develop an imaging system which can show for …
News

New managing director for Boehringer Ingelheim UK

January 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins

Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …
Appointment

NICE: Daily Mail ‘misled’ readers

January 13, 2014 Sales and Marketing Dillon, NHS, NICE, mail

UK drugs watchdog NICE has hit back at an article in the Daily Mail headlined “Champagne perks of NHS drug …
News

Sanofi pays $700m to expand rare disease portfolio

January 13, 2014 Research and Development, Sales and Marketing Alnylam, Sanofi, rare sidease

Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …
News

Thought leader mapping: do we need a radical rethink?

January 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Havas, bartley, marketing, sales, thought leader

The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …
Feature

New chief executive for Quanta Fluid Solutions

January 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing milad, quanta

Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive. Milad’s career spans 20 …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026